Effect of Vitamin D Repletion on Insulin Resistance and Systemic Inflammation
Completed · Phase 2 · Has a placebo group
Conditions studied: Insulin Resistance
In brief
The purpose of this research is to study the effects of Vitamin D supplementation on the body's response to insulin (a hormone that controls blood sugar), on inflammation, and on specific cells and processes in fat tissue.
Key facts
- Study ID
- NCT01354964
- Run by
- Albert Einstein College of Medicine
- People needed
- 19
- Starts
- 2009-03-13
- Expected to finish
- 2015-09-03
- Last updated by the study team
- 2020-11-02
Who can join
Age: 21 and older, up to 75. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Serum 25(OH)D<20ng/ml
- Insulin Resistant based on HOMA-IR score of >3
- Able and willing to provide informed consent
- BMI 20-35
You may not qualify if…
- HIV/AIDS
- History of any cancer
- Sarcoidosis
- Alcohol or substance abuse
- Cushing's syndrome
- Primary hyperparathyroidism
- Nephrolithiasis
- Pregnancy or breastfeeding
- Regular visits to a tanning salon
- Hypercalcemia or hypocalcemia
- Untreated or uncontrolled hypertension
- Any chronic illness requiring medication, other than arthritis, hypertension and hyperlipidemia
Where it is running
- Albert Einstein College of Medicine — The Bronx, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.